[ Maladie périodique ou fièvre méditerranéenne familiale (FMF) et grossesse: à propos d'un cas et revue de la littérature ]
Volume 13, Issue 1, September 2015, Pages 104–106
Jihad Drissi1, Farid Kassidi2, M. Hassani3, Jaouad Kouach4, Driss Rahali Moussaoui5, and Mohammed Dehayni6
1 Service de Gynécologie-Obstétrique, Hôpital militaire d'Instruction Mohammed V, Rabat, Morocco
2 Department of Gynecology-Obstetric, Military Training Hospital Med V, Rabat, Morocco
3 Service de Gynécologie Obstétrique de l'Hôpital Militaire, Rabat, Morocco
4 Faculté de Médecine et de Pharmacie, Université Mohamed V, Rabat, Morocco
5 Department of Gynecology-Obstetric, Military Training Hospital Med V, Rabat, Morocco
6 Department of Gynecology-Obstetric, Military Training Hospital Med V, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
Original language: French
Copyright © 2015 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction: Recurrent disease is a genetic autoinflammatory disease autosomal recessive with particular ethnic distribution. Chronic disease evolution paroxysmal often beginning at childhood and characterized by inflammation of the serous with the main risk amyloidosis. Colchicine is the standard treatment. The management of the carrier pregnant women with this disease should be done in collaboration between internist, obstetrician and nephrologist in patients with renal impairment.
Observation: We report the case of a woman in labor to 41 years, G5P2 mother of two children with a history of two spontaneous abortions, for MFM Followed by colchicine stopped since the desire to design with pregnancy marked by the occurrence of one crisis first trimester of pregnancy. The evolution was unremarkable and vaginal delivery of a newborn male eutrophic 10/10 Apgar.
Discussion and conclusion: FMF Treaty and colchicine have no major impact on the reproductive life of women of childbearing age subject to proper monitoring and good compliance. Obstetrical prognosis is especially marked by the increased risk of abortion in cases of early pregnancy crisis.
Author Keywords: periodic disease, autoinflammatory, colchicine, crises, abortion.
Volume 13, Issue 1, September 2015, Pages 104–106
Jihad Drissi1, Farid Kassidi2, M. Hassani3, Jaouad Kouach4, Driss Rahali Moussaoui5, and Mohammed Dehayni6
1 Service de Gynécologie-Obstétrique, Hôpital militaire d'Instruction Mohammed V, Rabat, Morocco
2 Department of Gynecology-Obstetric, Military Training Hospital Med V, Rabat, Morocco
3 Service de Gynécologie Obstétrique de l'Hôpital Militaire, Rabat, Morocco
4 Faculté de Médecine et de Pharmacie, Université Mohamed V, Rabat, Morocco
5 Department of Gynecology-Obstetric, Military Training Hospital Med V, Rabat, Morocco
6 Department of Gynecology-Obstetric, Military Training Hospital Med V, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco
Original language: French
Copyright © 2015 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Introduction: Recurrent disease is a genetic autoinflammatory disease autosomal recessive with particular ethnic distribution. Chronic disease evolution paroxysmal often beginning at childhood and characterized by inflammation of the serous with the main risk amyloidosis. Colchicine is the standard treatment. The management of the carrier pregnant women with this disease should be done in collaboration between internist, obstetrician and nephrologist in patients with renal impairment.
Observation: We report the case of a woman in labor to 41 years, G5P2 mother of two children with a history of two spontaneous abortions, for MFM Followed by colchicine stopped since the desire to design with pregnancy marked by the occurrence of one crisis first trimester of pregnancy. The evolution was unremarkable and vaginal delivery of a newborn male eutrophic 10/10 Apgar.
Discussion and conclusion: FMF Treaty and colchicine have no major impact on the reproductive life of women of childbearing age subject to proper monitoring and good compliance. Obstetrical prognosis is especially marked by the increased risk of abortion in cases of early pregnancy crisis.
Author Keywords: periodic disease, autoinflammatory, colchicine, crises, abortion.
Abstract: (french)
Introduction : La maladie périodique est une maladie auto-inflammatoire génétique à transmission autosomique récessive avec une répartition ethnique particulière. Maladie chronique d'évolution paroxystique débutant souvent à l'enfance et caractérisée par une inflammation des séreuses avec comme principal risque l'amylose. La colchicine est le traitement de référence. La prise en charge de la femme enceinte porteuse de cette maladie doit se faire en collaboration entre interniste, obstétricien et néphrologue en cas d'atteinte rénale.
Observation : Nous rapportons le cas d'une parturiente de 41ans, G5P2 mère de deux enfants avec antécédents de deux avortements spontanés, Suivie pour MFM sous colchicine arrêtée depuis le désir de conception, avec une grossesse marquée par la survenue d'une seule crise au premier trimestre de grossesse. L'évolution était sans particularités puis accouchement par voie basse d'un nouveau-né eutrophe sexe masculin Apgar 10/10.
Discussion et conclusion : La FMF traité ainsi que la colchicine n'ont pas de retentissement majeur sur la vie génital de la femme en âge de procréer sous réserve d'un suivi correcte et d'une bonne observance du traitement. Le pronostic obstétrical est surtout marqué par le risque accru d'avortement en cas de crise en début de grossesse.
Author Keywords: maladie périodique, auto-inflammatoire, colchicine, crises, avortement.
How to Cite this Article
Jihad Drissi, Farid Kassidi, M. Hassani, Jaouad Kouach, Driss Rahali Moussaoui, and Mohammed Dehayni, “Periodic disease or familial Mediterranean fever (FMF) and pregnancy: about a case and review of the literature,” International Journal of Innovation and Applied Studies, vol. 13, no. 1, pp. 104–106, September 2015.
